CN201130185Y - 莱克多巴胺elisa检测试剂盒 - Google Patents
莱克多巴胺elisa检测试剂盒 Download PDFInfo
- Publication number
- CN201130185Y CN201130185Y CNU2007201272969U CN200720127296U CN201130185Y CN 201130185 Y CN201130185 Y CN 201130185Y CN U2007201272969 U CNU2007201272969 U CN U2007201272969U CN 200720127296 U CN200720127296 U CN 200720127296U CN 201130185 Y CN201130185 Y CN 201130185Y
- Authority
- CN
- China
- Prior art keywords
- bottle
- ractopamine
- liquid
- solution
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002965 ELISA Methods 0.000 title claims abstract description 17
- 238000012360 testing method Methods 0.000 title description 6
- 229940074095 ractopamine Drugs 0.000 claims abstract description 33
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000243 solution Substances 0.000 claims abstract description 27
- 238000001514 detection method Methods 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 241001465754 Metazoa Species 0.000 claims abstract description 7
- 239000000427 antigen Substances 0.000 claims abstract description 6
- 102000036639 antigens Human genes 0.000 claims abstract description 6
- 108091007433 antigens Proteins 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 238000007689 inspection Methods 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 229920003023 plastic Polymers 0.000 claims description 17
- 239000004033 plastic Substances 0.000 claims description 16
- 239000012086 standard solution Substances 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 210000001951 dura mater Anatomy 0.000 claims description 2
- 210000004276 hyalin Anatomy 0.000 claims description 2
- 239000007790 solid phase Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 239000002984 plastic foam Substances 0.000 claims 1
- 238000002835 absorbance Methods 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 10
- 238000005406 washing Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 238000010790 dilution Methods 0.000 abstract description 4
- 239000012895 dilution Substances 0.000 abstract description 4
- 230000008878 coupling Effects 0.000 abstract description 3
- 238000010168 coupling process Methods 0.000 abstract description 3
- 238000005859 coupling reaction Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000007789 sealing Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 38
- 239000012530 fluid Substances 0.000 description 18
- 238000005538 encapsulation Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000002203 pretreatment Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 229940005654 nitrite ion Drugs 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 229960001399 clenbuterol hydrochloride Drugs 0.000 description 1
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960001089 dobutamine Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNU2007201272969U CN201130185Y (zh) | 2007-08-02 | 2007-08-02 | 莱克多巴胺elisa检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNU2007201272969U CN201130185Y (zh) | 2007-08-02 | 2007-08-02 | 莱克多巴胺elisa检测试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN201130185Y true CN201130185Y (zh) | 2008-10-08 |
Family
ID=40018046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNU2007201272969U Expired - Lifetime CN201130185Y (zh) | 2007-08-02 | 2007-08-02 | 莱克多巴胺elisa检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN201130185Y (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102778564A (zh) * | 2012-05-31 | 2012-11-14 | 华中农业大学 | 用于检测莱克多巴胺的单克隆抗体及酶联免疫方法与试剂盒 |
-
2007
- 2007-08-02 CN CNU2007201272969U patent/CN201130185Y/zh not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102778564A (zh) * | 2012-05-31 | 2012-11-14 | 华中农业大学 | 用于检测莱克多巴胺的单克隆抗体及酶联免疫方法与试剂盒 |
CN102778564B (zh) * | 2012-05-31 | 2014-06-04 | 华中农业大学 | 用于检测莱克多巴胺的单克隆抗体及酶联免疫方法与试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN201993363U (zh) | 林可霉素elisa检测试剂盒 | |
CN201535774U (zh) | 大观霉素elisa检测试剂盒 | |
CN201852838U (zh) | 磺胺喹噁啉elisa检测试剂盒 | |
CN103175798A (zh) | 苏丹红iv酶联免疫检测试剂盒 | |
CN201535773U (zh) | 庆大霉素elisa检测试剂盒 | |
CN201130186Y (zh) | 青霉素elisa检测试剂盒 | |
CN202614763U (zh) | 一种莱克多巴胺的免疫学检测试剂盒 | |
CN201130185Y (zh) | 莱克多巴胺elisa检测试剂盒 | |
CN201233399Y (zh) | 阿维菌素类药物elisa检测试剂盒 | |
CN201852835U (zh) | 呋喃它酮代谢物elisa检测试剂盒 | |
CN201535775U (zh) | 己烯雌酚elisa检测试剂盒 | |
CN201993364U (zh) | 卡那霉素elisa检测试剂盒 | |
CN201488998U (zh) | 苏丹红elisa检测试剂盒 | |
CN201993366U (zh) | 群勃龙elisa检测试剂盒 | |
CN201130184Y (zh) | 四环素elisa检测试剂盒 | |
CN202614766U (zh) | 一种黄曲霉毒素b1的免疫学检测试剂盒 | |
CN201438191U (zh) | 氯霉素elisa检测试剂盒 | |
CN202794039U (zh) | 检测呋喃它酮代谢物的化学发光试剂盒 | |
CN201852831U (zh) | 磺胺二甲氧嘧啶elisa检测试剂盒 | |
CN201130183Y (zh) | 呋喃唑酮代谢物elisa检测试剂盒 | |
CN202794175U (zh) | β-兴奋剂类ELISA检测试剂盒 | |
CN202720227U (zh) | 链霉素elisa检测试剂盒 | |
CN201852834U (zh) | 新霉素elisa检测试剂盒 | |
CN203981679U (zh) | 孔雀石绿残留检测elisa试剂盒 | |
CN201852837U (zh) | 炔诺酮elisa检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20090803 Pledge (preservation): Pledge |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20090803 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100712 Granted publication date: 20081008 Pledgee: Bank of Communications Ltd Beijing Zhongguancun Park sub branch Pledgor: Beijing hope Biotechnology Co., Ltd.|Beijing hope Kangtai Biotechnology Co., Ltd. Registration number: 2009110000584 |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20120515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100085 HAIDIAN, BEIJING TO: 102206 CHANGPING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120515 Address after: 102206 Huilongguan international information industry base, Changping District, high street, No. 8, No. four, Beijing Patentee after: Beijing Wanger Biotechnology Co., Ltd. Address before: 100085 Beijing city Haidian District Old Summer Palace Road No. 2 Zhongnongda National Veterinary Drug Safety Evaluation Center Co-patentee before: Beijing Wanger Biotechnology Co., Ltd. Patentee before: Beijing Wanger Biotechnology Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Luo Xiaoqin Document name: Notification of Passing Examination on Formalities |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20081008 |